ghk-cu vs bpc-157 comparison BPC-157/NAD+/GUK-Cu - Peptide Patch GHK‑Cu / BPC‑157 / TB‑500

For patients who want the data, we can add an optimization panel to track markers and refine the protocol over time

Standard Dosage Recommendations Injectable: 250500mcg per day, subcutaneously once or twice daily

NAD+ Injections After One Week By week one, energy levels often rise

Don't hesitate to reach out and learn more about how we can assist you

Lauzier A, Charbonneau M, Paquette M et al (2012) Transglutaminase 2 cross-linking activity is linked to invadopodia formation and cartilage breakdown in arthritis

Functional medicine practitioners are recognizing peptide therapy as a supportive treatment for Lyme disease